These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 12369844)

  • 1. Critical role of chromium (Cr)-DNA interactions in the formation of Cr-induced polymerase arresting lesions.
    O'Brien T; Mandel HG; Pritchard DE; Patierno SR
    Biochemistry; 2002 Oct; 41(41):12529-37. PubMed ID: 12369844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of mannitol or catalase on the generation of reactive oxygen species leading to DNA damage by Chromium(VI) reduction with ascorbate.
    Tsou TC; Lai HJ; Yang JL
    Chem Res Toxicol; 1999 Oct; 12(10):1002-9. PubMed ID: 10525278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of glutathione on chromium-induced DNA crosslinking and DNA polymerase arrest.
    O'Brien T; Xu J; Patierno SR
    Mol Cell Biochem; 2001 Jun; 222(1-2):173-82. PubMed ID: 11678599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential impact of ionic and coordinate covalent chromium (Cr)-DNA binding on DNA replication.
    Fornsaglio JL; O'Brien TJ; Patierno SR
    Mol Cell Biochem; 2005 Nov; 279(1-2):149-55. PubMed ID: 16283524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genotoxicity and mutagenicity of chromium(VI)/ascorbate-generated DNA adducts in human and bacterial cells.
    Quievryn G; Peterson E; Messer J; Zhitkovich A
    Biochemistry; 2003 Feb; 42(4):1062-70. PubMed ID: 12549927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia impedes the formation of chromium DNA-adducts in a cell-free system.
    O'Brien TJ; Mandel HG; Sugden KD; Komarov AM; Patierno SR
    Biochem Pharmacol; 2005 Dec; 70(12):1814-22. PubMed ID: 16242673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromium(VI) causes interstrand DNA cross-linking in vitro but shows no hypersensitivity in cross-link repair-deficient human cells.
    Morse JL; Luczak MW; Zhitkovich A
    Chem Res Toxicol; 2013 Oct; 26(10):1591-8. PubMed ID: 24059640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of chromium(VI) by ascorbate leads to chromium-DNA binding and DNA strand breaks in vitro.
    Stearns DM; Kennedy LJ; Courtney KD; Giangrande PH; Phieffer LS; Wetterhahn KE
    Biochemistry; 1995 Jan; 34(3):910-9. PubMed ID: 7827049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incision of trivalent chromium [Cr(III)]-induced DNA damage by Bacillus caldotenax UvrABC endonuclease.
    O'Brien TJ; Jiang G; Chun G; Mandel HG; Westphal CS; Kahen K; Montaser A; States JC; Patierno SR
    Mutat Res; 2006 Nov; 610(1-2):85-92. PubMed ID: 16890479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reductive activation with cysteine represents a chromium(III)-dependent pathway in the induction of genotoxicity by carcinogenic chromium(VI).
    Zhitkovich A; Quievryn G; Messer J; Motylevich Z
    Environ Health Perspect; 2002 Oct; 110 Suppl 5(Suppl 5):729-31. PubMed ID: 12426121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carcinogenic chromium(VI) induces cross-linking of vitamin C to DNA in vitro and in human lung A549 cells.
    Quievryn G; Messer J; Zhitkovich A
    Biochemistry; 2002 Mar; 41(9):3156-67. PubMed ID: 11863455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Undetectable role of oxidative DNA damage in cell cycle, cytotoxic and clastogenic effects of Cr(VI) in human lung cells with restored ascorbate levels.
    Reynolds M; Armknecht S; Johnston T; Zhitkovich A
    Mutagenesis; 2012 Jul; 27(4):437-43. PubMed ID: 22241526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complexities of chromium carcinogenesis: role of cellular response, repair and recovery mechanisms.
    O'Brien TJ; Ceryak S; Patierno SR
    Mutat Res; 2003 Dec; 533(1-2):3-36. PubMed ID: 14643411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Base-specific arrest of in vitro DNA replication by carcinogenic chromium: relationship to DNA interstrand crosslinking.
    Bridgewater LC; Manning FC; Patierno SR
    Carcinogenesis; 1994 Nov; 15(11):2421-7. PubMed ID: 7955085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-oxidative mechanisms are responsible for the induction of mutagenesis by reduction of Cr(VI) with cysteine: role of ternary DNA adducts in Cr(III)-dependent mutagenesis.
    Zhitkovich A; Song Y; Quievryn G; Voitkun V
    Biochemistry; 2001 Jan; 40(2):549-60. PubMed ID: 11148050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reductive metabolism of Cr(VI) by cysteine leads to the formation of binary and ternary Cr--DNA adducts in the absence of oxidative DNA damage.
    Zhitkovich A; Shrager S; Messer J
    Chem Res Toxicol; 2000 Nov; 13(11):1114-24. PubMed ID: 11087433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arrest of replication by mammalian DNA polymerases alpha and beta caused by chromium-DNA lesions.
    Bridgewater LC; Manning FC; Patierno SR
    Mol Carcinog; 1998 Dec; 23(4):201-6. PubMed ID: 9869448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pro-oxidative vs antioxidative properties of ascorbic acid in chromium(VI)-induced damage: an in vivo and in vitro approach.
    Poljsak B; Gazdag Z; Jenko-Brinovec S; Fujs S; Pesti M; Bélagyi J; Plesnicar S; Raspor P
    J Appl Toxicol; 2005; 25(6):535-48. PubMed ID: 16092082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromium(VI) treatment of normal human lung cells results in guanine-specific DNA polymerase arrest, DNA-DNA cross-links and S-phase blockade of cell cycle.
    Xu J; Bubley GJ; Detrick B; Blankenship LJ; Patierno SR
    Carcinogenesis; 1996 Jul; 17(7):1511-7. PubMed ID: 8706257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of the in vitro genotoxicity of tri- and hexavalent chromium.
    Blasiak J; Kowalik J
    Mutat Res; 2000 Aug; 469(1):135-45. PubMed ID: 10946250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.